Becton, Dickinson and Company recalls Swan-Ganz Jr Catheter, Models: SGPT54, SGPT64P, SGPT755P
- Recall date
- April 8, 2026
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- Z-2203-2026
- FDA classification
- Class II
- Brand / firm
- Becton, Dickinson and Company
- Sold / distributed
- Worldwide - US Nationwide distribution including in the states of TX, SC, CT, GA, VA, MO, NM, UT, NJ, CA, FL, PA, IN, TN, WA, KY, MD, WV, MI, MA, NC, MN, NY, AZ, AL, LA, CO, OK, HI, MS, IL, OH, NE, DC, KS, NV, WI, SD, IA, AR, ID, OR, WY, MT, RI, VT, DE, AK, NH, ND, ME, PR and the countries of Japan…
Why it was recalled
Catheters may, due to a manufacturing process and material changes, leak/break from the (blue) proximal injectate lumen hub, which may lead to infection, medication loss, and/or blood loss.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Swan-Ganz Jr Catheter, Models: SGPT54, SGPT64P, SGPT755P
Get recall alerts
Free email alert whenever Becton, Dickinson and Company has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Becton, Dickinson and Company